i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
Rapid diagnostic HCV antibody assays
-
Published Date:
Dec 07 2012
-
Publisher's site:
-
Source:Antivir Ther. 17(7 Pt B):1409-1413.
-
Details:
-
Alternative Title:Antivir Ther
-
Personal Author:
-
Description:Approximately 4.1 million Americans have been infected with HCV and 45-85% of chronically infected persons are unaware of their status. Rapid anti-HCV assays can assist and expedite the identification of those unaware of their infection. Performance characteristics of pre-market rapid anti-HCV assays (Chembio, MedMira and OraSure) have been evaluated. Their sensitivity (78.9-99.3%) and specificity (80-100%) varied. Future investigations could include evaluation of rapid anti-HCV tests in persons who are coinfected with HCV and HIV, and development of rapid HCV-antigen tests and nucleic acid tests.
-
Subject:
-
Pubmed ID:23322678
-
Pubmed Central ID:PMC5791540
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/xml
No Related Documents.